DNA RNA and Cells
20 August 2015
VBL Therapeutics Announces First Patient Dosed in Pivotal Phase 3 Trial of VB-111 in Recurrent Glioblastoma18 August 2015
Progressing Towards Clinical Trials: Kadimastem Proves Efficacy of Its Unique ALS Treatment in Pre-Clinical Trials18 August 2015
Kite Pharma Provides Update on KTE-C19 Clinical Trial10 August 2015
Aduro Biotech Completes Enrollment in Phase 1b Clinical Trial of CRS-207 Immunotherapy for the Treatment of Mesothelioma10 August 2015
Hemostemix Receives FDA Clearance for Phase-2 Clinical Trial of Lead Product ACP-01 in the United States4 August 2015
Collaboration to Develop mRNA Vaccines Expands30 July 2015
Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine29 July 2015
Inovio Pharmaceuticals’ DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge21 July 2015
Isis Pharmaceuticals Initiates Clinical Study of ISIS-HTT Rx in Patients With Huntington’s Disease21 July 2015
ERYTECH announces positive safety review for ERY-ASP in its Phase 2 study in pancreatic cancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports